RU93015155A - MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES - Google Patents

MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES

Info

Publication number
RU93015155A
RU93015155A RU93015155/14A RU93015155A RU93015155A RU 93015155 A RU93015155 A RU 93015155A RU 93015155/14 A RU93015155/14 A RU 93015155/14A RU 93015155 A RU93015155 A RU 93015155A RU 93015155 A RU93015155 A RU 93015155A
Authority
RU
Russia
Prior art keywords
medicine
injuries
treatment
eye tissues
dystrophic diseases
Prior art date
Application number
RU93015155/14A
Other languages
Russian (ru)
Inventor
С.А. Кедик
В.И. Свергун
Е.И. Ярцев
Original Assignee
Фармацевтическая фирма "Ковидон"
Filing date
Publication date
Application filed by Фармацевтическая фирма "Ковидон" filed Critical Фармацевтическая фирма "Ковидон"
Publication of RU93015155A publication Critical patent/RU93015155A/en

Links

Claims (1)

Использование: в качестве лекарственного средства для лечения дистрофических заболеваний и травм глазных тканей в медицине. Средство содержит, в мас.%: тауфон 1,0 - 2,0; нипагин 0,05 - 0,1; водорастворимый сополимер 2-метил-5-винилпиридина и N-винилпирролидона 0,05 - 2,0, вода - остальное. В подкисленный водный раствор сополимера добавляют тауфон в виде порошка или раствора и нипагин и доводят водный раствор до необходимой концентрации. Средство нетоксично, снижает частоту помутнений хрусталика до 46,8%.Usage: as a medicine for the treatment of degenerative diseases and injuries of eye tissues in medicine. The tool contains, in wt.%: Taufon 1.0 to 2.0; nipagin 0.05 - 0.1; water-soluble copolymer of 2-methyl-5-vinylpyridine and N-vinylpyrrolidone 0.05 - 2.0, water - the rest. In the acidified aqueous solution of the copolymer add taufon in the form of a powder or solution and nipagin and bring the aqueous solution to the required concentration. The tool is non-toxic, reduces the frequency of lens opacities to 46.8%.
RU93015155/14A 1993-03-23 MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES RU93015155A (en)

Publications (1)

Publication Number Publication Date
RU93015155A true RU93015155A (en) 1995-09-10

Family

ID=

Similar Documents

Publication Publication Date Title
DK0418339T3 (en) Preparation and Method for Preventing Tissues Between Body Tissues
RU93056633A (en) ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE
DK0594770T3 (en) Ophthalmological mixtures
BR9708388A (en) Aqueous solution of pyridoxylated polymerized hemoglobin and the process for its preparation.
NZ533483A (en) Combinations of viscoelastics for use during surgery
RU93015155A (en) MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES
EP0453337A3 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use
FR2656527B1 (en) EYE IRRIGATION SOLUTION USED IN THERAPEUTICS FOR ENDOTHELIAL PROTECTION AND CONSERVATION OF THE CORNEA.
PT711163E (en) USE OF BENZIDAMINE IN THE TREATMENT OF TNF-INDUCED PATHOLOGICAL STATES
RU2073523C1 (en) Preparation for treatment of burn disease of eye of i-iv degree
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
RU95119728A (en) GEL FOR SKIN CARE AND ITS TREATMENT AND COMPOSITION FOR ITS PRODUCTION
FR2315949A1 (en) Ophthalmic soln. for use with contact lenses and medications - comprises aq. soln. of polyacrylamide and PEG
RU99108789A (en) INHIBITOR OF SUBEPITELIAL POGGENITS
RU93032280A (en) METHOD FOR KERATOPROTESIS OF VASCULAR SLEEVED BELMAS
GR3018349T3 (en) Use of naproxen as mydriatic agent.
BG51485A1 (en) Ophthalmological medicamentous preparation
FR2580502B1 (en) USE OF "NAFTIDROFURYL" IN THE PREPARATION OF A MEDICINAL PRODUCT
RU93019277A (en) SOLUTION FOR THE PROTECTION AND TREATMENT OF DISEASES AND DAMAGE TO THE CORNICE VIZITON
RU96118559A (en) MEDICINE
RU98109064A (en) EYE FILMS
RU94000179A (en) Eye gel
RU93051600A (en) ANTI-MICROBIAL AND ANTIVIRAL AGENT